Ballicules.com

Quazepam

DORAL

What it isLong-acting benzodiazepine GABA-A modulator approved for insomnia.

Why this oneIts long-lived active metabolites can maintain sleep through the night, but it has no routine advantage over shorter-acting hypnotics.

What limits itNext-day impairment, falls, and accumulation are prominent, especially in older adults; tolerance and physical dependence develop.

FDA-approved for

FDA label

BOXED WARNING Concomitant opioid use risks profound sedation, respiratory depression, coma, death; risk of abuse, misuse, addiction; and dependence with withdrawal reactions.
FDA dosingPopulationStartTargetMax
InsomniaAdults7.5 mg QHS7.5 mg QHS15 mg QHS

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Late-pregnancy use may cause neonatal sedation/withdrawal; observational data show no clear major-birth-defect association.

Lactation Undefined

⚠ BOXED WARNINGS

Cost, est. cash$30–$250/month

Generic entryBy 2023

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability3 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilitySedation, falls, dependence and additive respiratory depression with opioids or other CNS depressants.

Mechanism of action: Quazepam ballicule

Quazepam ballicule: receptor binding, kinetics and half-life diagram

Open Quazepam in the interactive console ↗

Memory aids: mascots and interaction avatars

Quazepam DORAL mascot mnemonic cartoon
“Quasi’s all Door”
Quazepam CYP3A4 substrate avatar
CYP3A4 substrate

Open Quazepam in the interactive console ↗